Latest / Deep Dive Ortho — Orthopaedic Surgery, AI & Digital Health Podcast. / Classic Papers in Orthopaedics

Transcript

Classic Papers in Orthopaedics · Deep Dive Ortho — Orthopaedic Surgery, AI & Digital Health Podcast.

0:00
Welcome back to the Deep Dive. Today we're embarking
0:03
on a truly foundational exploration. We're diving
0:06
deep into a stack of source material that reviews
0:09
the classic papers, the landmark research that
0:12
have fundamentally shaped the field of orthopedics.
0:15
Indeed. And our mission today really is to unpack
0:18
some of those foundational concepts, look at
0:21
how techniques evolved, and critically, explore
0:24
the nature of research and evidence itself within
0:27
orthopedics. Exactly. And as the source material
0:30
highlights right from the start, this isn't just
0:33
about creating a simple list. There's a fascinating
0:36
challenge. What actually makes a paper classic?
0:40
Well, it's not always straightforward, is it?
0:42
Many journals might default to metrics like citation
0:45
frequency, aiming for something objective. But
0:48
the editors behind this review realize that just
0:50
counting citations, well, it doesn't always capture
0:52
the true essence or the lasting impact of a paper.
0:55
That's spot on. Citation counts are, you know,
0:57
one piece of data, but they don't tell the whole
0:59
story. They don't necessarily correlate with
1:01
genuine transformation in the field. Precisely.
1:04
They found that this sort of number crunching,
1:07
while giving you a rank, didn't always highlight
1:09
the papers that had truly shifted thinking or
1:11
practice. So their goal was to add substance,
1:15
to look beyond just the numbers. And they landed
1:17
on a richer definition. Yes, a more nuanced view.
1:20
A classic paper, they argued, is one that left
1:22
an indelible mark. Perhaps it was one -of -a
1:25
-kind when published, and crucially, it had a
1:28
significant impact. It changed clinical opinion,
1:31
or it steered future research in a new direction.
1:33
That makes a lot more sense, and they give examples
1:35
that really illustrate this point, don't they?
1:37
Even papers that might seem like lower -level
1:39
evidence today. Absolutely. Think of Sir John
1:42
Charnley's work on total hip replacement, or
1:45
Dr. Ignacio Ponsetti's methods for treating clubfoot.
1:48
Case series, essentially. Exactly. Level five
1:51
evidence by today's hierarchy. Yet their influence
1:54
on practice globally was and still is just immense.
1:58
They didn't just add to the literature. They
2:00
fundamentally reshaped treatment for millions.
2:03
So their clinical impact really cemented their
2:05
classic status, regardless of the study design
2:07
itself. That's the key distinction. It's about
2:11
transformative influence, not just statistical
2:13
rigor in isolation. And this source material
2:16
covers a huge range. Hip. spine, knee, hand,
2:21
basic science, trauma, pediatrics. It's a real
2:24
journey through orthopedic history. It is. And
2:26
navigating this history with us, helping connect
2:29
these pivotal moments is our expert guide for
2:31
today. I'm delighted to explore these landmark
2:33
contributions with you. It really is like peering
2:36
back at those moments of major breakthrough.
2:38
OK, let's really get into it then. Building on
2:41
that idea, defining classic by impact. Let's
2:44
dive straight into total hip arthroplasty, THA.
2:48
The source calls it one of the most successful
2:50
operations of the 21st century. Arguably, yes.
2:53
And its history is traceable right through these
2:55
key papers. It's an incredible success story,
2:57
definitely. But it wasn't a straight line to
3:00
success. You have the initial groundbreaking
3:02
work, Charlie's low -friction concept, for instance.
3:04
But the early days had problems. Oh, yes. The
3:07
source details the, well, the disappointing results
3:10
with the first -generation cementing techniques.
3:13
And perhaps surprisingly now, Early unsmented
3:16
implants also faced significant hurdles. So it
3:19
was a learning process. Absolutely. Continuous
3:22
refinement driven by observing failures and trying
3:24
to understand why they were happening. And a
3:27
big part of that early understanding was tackling
3:29
this problem they initially called cement disease.
3:32
That's right. Early on, they noticed bone loss,
3:35
osteolysis, mostly around cemented implants.
3:38
So naturally, the assumption was the cement itself
3:41
was the problem. Ends the name. Exactly. But
3:43
then a really pivotal paper by Goldring and colleagues
3:46
in 1983 shed much more light on it. They did
3:50
detailed histological assessment. Looking at
3:52
the tissue right at the implant interface. Yes,
3:54
that thin, fibrous membrane that often formed
3:56
between the implant and the bone, especially
3:58
where you saw this bone loss. And what did they
3:59
actually find there? They discovered it was packed
4:02
with macrophages. you know, immune cells. And
4:05
crucially, the tissue had a distinct organization,
4:08
surprisingly similar, actually, to the synovial
4:11
membrane lining joints. So an inflammatory reaction.
4:14
A significant one. These macrophages were actively
4:17
producing high levels of pro -inflammatory things
4:20
like prostaglandin E2, PGE2, and collagenase
4:24
enzymes that can break down bone and collagen.
4:26
Right. So it pointed towards a biological response,
4:29
not just the cement. failing mechanically. Exactly,
4:33
that shifted the focus. But then came another
4:35
crucial turn in understanding. Which was? They
4:37
started seeing these same little -itians, this
4:39
bone resorption, around cementless implants too.
4:42
Ah, so it couldn't just be the cement. Precisely.
4:45
That observation proved unequivocally that cement
4:47
wasn't the sole cause, maybe not even the primary
4:50
cause. The understanding evolved dramatically.
4:52
And that led to the term we use now. Yes. Particle
4:55
disease. Osteolysis around implants is now almost
4:58
universally understood as particle disease. Caused
5:01
by the tiny bits of wear debris from the implant
5:04
surfaces. Spot on. The mechanism, refined through
5:07
work by people like Willard and Semlich and Anthony
5:10
and colleagues, is essentially this. Mechanical
5:13
wear at the articulating surfaces, the ball moving
5:16
in the socket, generates tiny particles. From
5:19
the plastic or metal or ceramic? Yes, whatever
5:22
the bearing surface is made of. This debris gets
5:25
ingested by macrophages phagocytosis. This activates
5:29
the macrophages. Prompting them to release those
5:31
inflammatory chemicals Goldring identified. Exactly.
5:34
Which in turn stimulate osteoclasts, the cells
5:37
that actually absorb bone. Willard and Semlich
5:40
really described this cellular reaction well.
5:42
And Anthony added the migration piece. Yes, suggesting
5:45
polyethylene debris could migrate through tiny
5:48
gaps, maybe between the implant and cement, or
5:50
implant and bone in uncemented cases, reaching
5:53
the endosteal surface and triggering resorption
5:55
there. So while the exact molecular pathways
5:58
are still studied, the fundamental concept was
6:01
established. Accessible wear particles drive
6:03
inflammation leading to bone loss and loosening.
6:05
That was a massive leap forward in understanding
6:07
why THAs failed. That conceptual shift from blaming
6:11
the material, the cement, to understanding a
6:14
biological reaction to wear particles that's
6:17
huge for implant design and improvement, isn't
6:19
it? Absolutely fundamental. Now, beyond understanding
6:22
why hips failed, surgeons obviously needed ways
6:24
to measure how well they were actually performing.
6:26
The source mentions orthopedics was maybe a bit
6:29
slow on the uptake with outcome measures? Well,
6:32
perhaps compared to some other medical fields,
6:34
yes. The need for objective numerical systems
6:37
to describe a patient's status before and after
6:40
surgery really became clear in the 1950s. The
6:44
aim was to quantify results with a single number.
6:46
And this started with systems like Larson's.
6:48
Right. Larson's 1962 system was an early attempt,
6:51
a 100 -point scale looking at pain, function,
6:54
motion, deformity, gait. Then came the Harris
6:57
hip score in 1969 from Dr. William Harris. Also
7:01
100 points, but weighted differently. Very differently.
7:04
Harris put huge emphasis on pain 44 points and
7:07
function 47 points. That left very little for
7:09
range of motion, only five points and absence
7:12
of deformity, just four points. So heavily prioritizing
7:15
pain relief and getting people moving again functionally.
7:17
It did. But both Larsen's and the early Harris
7:21
score, while useful steps, had limitations, didn't
7:24
they? Condensing everything into one number makes
7:27
it hard to see an individual's specific problems
7:30
or improvements. Right, and then there was the
7:32
Merleau de Bunye -Postel score. Yes, developed
7:34
in 1970. It aimed for simplicity, giving individual
7:38
scores for pain, mobility, and walking ability,
7:41
often shown in a table. It was later modified
7:44
by MATA and others, refining the grading, especially
7:47
for motion, and adjusting the pain and ambulation
7:50
scales slightly. And that one's still used quite
7:52
a bit. It is, widely accepted internationally.
7:54
Yeah. Perhaps less so in North America than the
7:56
Harris HIP score, which really gained traction
7:58
there. But the source is quite critical of HIP
8:01
scores in general, isn't it? Pointing out weaknesses.
8:03
It is, quite rightly. A major issue is the lack
8:06
of uniformity between different scoring systems.
8:08
And objectivity is a concern. How so? Well, critical
8:12
studies showed you could get conflicting assessments
8:14
of success in the same patient just by using
8:16
different scores. Plus, many lacked robust validation.
8:20
And the Harris -Hipp score itself, despite being
8:22
so common. The source notes, even the HHS has
8:25
only been partially tested for reliability and
8:27
validity. And this highlights a crucial point
8:30
made by Smith and others. Just showing a new
8:33
score correlates with an old score criteria validity.
8:36
Validity doesn't prove the new score actually
8:39
measures what it's intended to measure. Or what
8:41
matters most to the patient. Exactly. Does it
8:43
capture the quality of life aspects patients
8:46
value? The HHS might not fully do that. Many
8:49
authors now argue you need to combine these scores
8:51
with patient reported outcome measures, PROMs,
8:54
like the SF -36 or WOMAC, for a fuller picture.
8:57
So these scores were a necessary start, but later
9:00
research revealed their limits in terms of uniformity,
9:02
objectivity, and capturing the full patient experience.
9:05
That's a fair summary. Beyond functional scores,
9:08
understanding failure also relied heavily on
9:10
looking at x -rays, radiographic evaluation.
9:13
And interpreting those x -rays after hip replacement
9:15
brought its own challenges. Take the Barrett
9:17
grading for femoral cementing quality. Designed
9:19
to predict outcomes based on how good the cement
9:22
mantle looked. Yes, but studies found poor agreement
9:25
between different surgeons looking at this same
9:26
x -ray. Poor reproducibility. Only moderate agreement
9:30
in one study mentioned that inconsistency makes
9:33
it hard to use reliably for comparing results.
9:37
And the radiographic signs of loosening itself,
9:39
what were they looking for? Early signs included
9:41
things like the cement actually fracturing or
9:44
seeing radiolucent lines basically gaps or clear
9:47
zones at the interface between the stem and cement
9:50
or the cement and bone. And how common was that?
9:53
A retrospective review mentioned in the source
9:55
looked at cemented stems and found nearly 20%,
9:58
19 .5%, showed these radiographic signs. But
10:02
it's nuanced. How so? Well, the source points
10:04
out that thin radiolucent lines in certain areas,
10:07
like gruin zone 1 up near the top corner of the
10:09
femur, are actually quite common and often don't
10:12
mean there's a clinical problem. But wider gaps
10:14
are more worrying. Yes, wide lucency, specifically
10:17
in gruin zone 1, are considered strong evidence
10:19
of actual loosening. And Dr. Harris, who developed
10:22
the score, also refined his ideas on radiographic
10:25
loosening over time. He did. Initially, he had
10:28
categories like possible, probable, definite
10:31
loosening based on how much radiolusancy you
10:33
saw, or signs of the implant shifting or the
10:36
cement cracking. But he changed that later. Yes.
10:39
By 1993, he'd abandoned probable and possible,
10:42
focusing only on definite loosening criteria.
10:45
Why the shift? What prompted that? It was significantly
10:48
influenced by autopsy studies. Looking at well
10:51
-functioning cemented stems from patients who'd
10:53
passed away from other causes. And what did those
10:55
studies show? They revealed that many of those
10:58
radiolucent lines seen on x -ray, interpreted
11:00
as potential loosening, were actually just normal
11:03
bone remodeling happening next to the cement
11:05
and dostyle remodeling, not a failure of fixation.
11:08
I see. So the X -ray appearance wasn't always
11:10
what it seemed. Exactly. So Harris refined his
11:13
criteria to be more specific, later defining
11:15
femoral osteolysis as a focal area of bone loss,
11:19
wider than two millimeter, distinguishing it
11:21
from those thinner, linear lines. It's a subtle
11:24
but important distinction, sometimes missed in
11:26
later papers citing his work. And what about
11:29
the socket side, the acetabulum? Was it similar?
11:32
Radiographic signs there... mainly a radiolusin
11:34
line at the cement interface, also correlated
11:37
with finding the cup loose during revision surgery.
11:40
If you saw a line in just one zone, the chance
11:43
of it being loose was low, maybe 7%. But if you
11:46
saw lines all around... If lines were in all
11:49
three zones, the likelihood jumped to 94%. And
11:52
if there was migration or fracture as well, it
11:54
was 100 % loose intraoperatively. But again,
11:57
a nuance. Yes. Interestingly, the incidence of
12:00
radiographic asapabular loosening was often much
12:03
higher than the rate of actual clinical failure
12:05
needing revision. So the exact relationship between
12:07
the x -ray look and the clinical outcome remained
12:10
a bit uncertain for a while. It sounds like reading
12:13
post -op x -rays involves quite a bit of interpretation,
12:16
maybe more art than pure science sometimes. There's
12:18
certainly an element of experience involved,
12:20
yes. Now, looking at how long these hips lasted,
12:23
the long -term outcome data from big centers
12:25
must have been crucial. The Mayo Clinic's Charnley
12:28
series is a classic example mentioned. Absolutely.
12:31
Beckenbaugh and Ilstrup published key reviews
12:33
of Mayo's extensive experience with Charnley
12:35
THAs, starting back in 1969. Their follow -up,
12:39
tracking patients and hips out to 20 years showed
12:42
a really remarkable 84 % probability of the hip
12:46
surviving without needing revision. That's impressive,
12:49
especially for early data. It really was. A landmark
12:52
paper showing the long -term durability of cemented
12:54
THA with good technique. It also powerfully showed
12:57
how age influenced outcomes. In what way? Patients
13:00
over 70 had a significantly lower risk of needing
13:03
revision, only 12%, compared to younger patients
13:06
under 59, where the risk was higher, around 27%.
13:09
That 20 -year survival figure really showed this
13:12
wasn't just a short -term fix. The source also
13:14
compares different early implant designs, doesn't
13:16
it, like Charnley versus Muller? Yes, these were
13:18
two very common cemented stem designs in the
13:20
early 70s. Stauffer and colleagues reported the
13:23
Mayo results for the Charnley stem. loosing around
13:25
24 % at five years, 30 % at 10 years. And the
13:28
Mueller. Sutherland and Associates reported on
13:30
the Mueller prosthesis finding a higher rate
13:33
of femoral loosening about 34 % at 10 years.
13:36
So the Mueller stem seemed to loosen more often
13:38
on the thigh bone side. Did the source suggest
13:41
why? Yes, several potential reasons were put
13:44
forward. The curved shape of the Mueller stem
13:46
made getting a perfect uniform cement mantle
13:49
trickier. It often ended up slightly angled inwards,
13:53
in varus, which could concentrate stress. Other
13:55
factors. The molar stem also had a rather sharp,
13:58
thin edge on the inner side, thought to increase
14:00
stress in the cement, possibly leading to fragmentation.
14:04
And finally, the stem itself was often quite
14:06
narrow compared to the canal, meaning you needed
14:08
a thicker layer of cement. And a very thick cement
14:11
layer isn't always better. No. A very thick mantle
14:14
can actually be weaker than a thinner, well -interdigitated
14:17
one. So these comparisons fed directly back into
14:20
improving implant design and cementing techniques.
14:23
All learned through meticulous follow -up and
14:25
analysis documented in these papers. What about
14:27
using THA in younger, maybe more active patients?
14:31
The Mayo data showed age was a factor. Yes. The
14:34
Massachusetts General Hospital study looked specifically
14:37
at this challenging group. They reviewed 29 young
14:39
patients, 33 hips in total. And the results?
14:42
Well, the initial results at 10 months looked
14:44
okay, but the medium -term follow -up out to
14:47
five years, revealed a more concerning picture.
14:50
57 % over half showed actual or potential loosening
14:54
of at least one component. That's dramatically
14:56
different from the older patient data. It certainly
14:59
is. And they found loosening of the socket, the
15:01
acetabular component, was more than twice as
15:04
common as femoral loosening in these younger
15:06
patients. Did they identify factors linked to
15:08
these poor results? Yes. Several things were
15:11
associated. Yeah. Having had a previous operation,
15:14
like a mold cup, arsoplasty, being highly active
15:17
after the hip replacement, having only one hip
15:20
replaced, maybe putting more stress on it, and
15:22
having a body weight over 82 kilograms. So it
15:25
really highlighted that the demands on a THA
15:27
are much higher in younger, active people. Definitely.
15:31
It showed different failure patterns and stressed
15:33
the need for careful patient selection. maybe
15:36
different approaches in this group. You couldn't
15:38
just extrapolate the success in older, less active
15:41
individuals. That gives us a really comprehensive
15:43
view of how THA understanding evolved. The breakthroughs,
15:48
the setbacks, the changing ideas about failure,
15:51
the measurement challenges. OK, let's shift gears
15:54
now. Let's explore classic insights from the
15:57
spine and then the knee. Absolutely. Equally
16:00
important areas with their own rich research
16:02
history documented here. Low back pain. for instance,
16:06
ubiquitous, isn't it? As Baker's review highlights,
16:08
it has so many potential causes. And researchers
16:11
tried pinpointing risk factors. Yes. Baker also
16:14
did an epidemiological survey looking at environmental
16:16
exposures, workplace, recreation. They did identify
16:20
some risk factors. But as the source notes, translating
16:24
that knowledge into successful widespread prevention
16:26
strategies has Well, remain quite challenging,
16:29
unfortunately. And treating nonspecific low back
16:31
pain conservatively sounds like a complex area
16:33
too. Baker's systematic review found the literature
16:36
just incredibly varied, heterogeneous, and often
16:39
contradictory. Assessing how well different non
16:42
-surgical treatments work is really difficult
16:44
because the studies are so different in design,
16:46
patient groups, and how they measure outcomes.
16:48
And this is where Waddell and colleagues introduced
16:50
their concept of non -organic physical signs.
16:53
Yes. Their paper put forward the idea that for
16:56
some patients with significant back pain -related
16:59
distress and disability, it might not all be
17:02
explained by identifiable anatomical issues.
17:05
So psychosocial factors playing a role? Potentially
17:08
a significant role. They describe specific clinical
17:11
signs to look for during an examination that,
17:14
if present, might suggest these factors are important
17:17
in that patient's overall picture and perception
17:19
of disability. Sort of screening tool. Moving
17:22
to specific pathology, lumbar disc prolapse.
17:25
What did classic papers show about treatment?
17:28
A key reference is a randomized controlled trial
17:30
comparing conservative care versus surgical disectomy
17:33
for patients with clear, radicular pain confirmed
17:36
by radiculography. How did they design that trial?
17:39
They initially observed patients for 14 days.
17:41
Anyone with very severe symptoms or who improved
17:44
quickly was excluded. Those left with persistent
17:46
significant pain were then randomized, either
17:49
continue conservative care or have surgery. And
17:51
the results of that head -to -head comparison?
17:53
At the one -year follow -up, the group that had
17:56
surgery, the disectomy, showed a statistically
17:59
significant better outcome compared to the group
18:02
managed conservatively. So important evidence
18:04
for guiding decisions in selected patients. Yes.
18:07
for those with persistent radiculopathy from
18:10
a disc prolapse. What about spinal stenosis,
18:12
the narrowing of the canal? Verbius Taper was
18:14
foundational. He was the first to clearly describe
18:17
the classic symptoms of neurogenic claudication,
18:21
that leg pain, numbness, weakness brought on
18:23
by walking, relieved by sitting or bending forward.
18:26
Linked to canal narrowing. Exactly. And he reported
18:29
successful results with surgical decompression.
18:32
Interestingly, he initially thought the narrowing
18:35
was developmental. An anomaly. But later research
18:37
showed otherwise. Yes. Subsequent work, often
18:40
building on his descriptions, showed that degenerative
18:43
changes, facet joint hypertrophy, ligamentum
18:45
flasum thickening, disc bulging, are actually
18:48
a much more common cause, especially in older
18:49
adults. Even the age range in Verbius' original
18:52
study 36 to 67 suggests degenerative factors
18:55
were likely involved in many cases. Shifting
18:58
to spinal deformity scoliosis. Harrington's name
19:01
is synonymous with surgery here. Dr. Paul Harrington
19:04
truly revolutionized scoliosis surgery. His classic
19:08
paper described a new technique using stainless
19:10
steel rods and hooks. To straighten the spine?
19:12
Yes, applying distraction and compression forces
19:15
to correct and stabilize the curves, usually
19:17
combined with spinal fusion. His work, refined
19:20
over several case series, was a major advance
19:23
over previous, less effective methods and became
19:26
the standard for decades. And for spinal trauma?
19:29
Dennis's classification of thoracolumbar fractures
19:31
was key. Hugely important for understanding stability
19:34
after injury. Dennis emphasized the middle column,
19:37
posterior ligament, posterior annulus, posterior
19:40
vertebral body wall. Crucial for stability and
19:43
neurological risk. Precisely. His classification
19:46
aimed to identify fractures at high risk of neurological
19:48
problems or mechanical instability, helping decide
19:52
when surgery might be needed. It integrated biomechanics,
19:55
injury mechanism, x -ray findings, and outcomes.
19:58
Identifying patterns like burst fractures is
20:00
particularly risky. Yes. It greatly improved
20:03
communication and allowed better comparison of
20:06
treatment results for different fracture types.
20:08
And the source also mentions Cloward's pioneering
20:10
work on anterior cervical dissectomy and fusion
20:13
as another key spine paper. Okay, let's pivot
20:17
to the knee now. Classic paper is shaping our
20:19
understanding there. The V, like the hip. heavily
20:22
researched. Understanding ligament function was
20:25
critical early on. Mark Alff and colleagues'
20:28
1976 cadaveric study was a big step forward in
20:31
biomechanics. What made it so important? They
20:34
provided quantitative measurements. How much
20:36
did each ligament contribute to stability in
20:38
different directions at different knee angles?
20:40
It moved beyond just description to actual numbers.
20:42
So more objective data. Yes. Showing, for instance,
20:45
how a ligament's role changes depending on whether
20:48
the knee is straight or bent or the direction
20:50
of force. This directly informed our understanding
20:53
of clinical stability tests. Helping understand
20:55
why we do certain tests at certain angles. Exactly.
20:59
What ligaments are being stressed. While manual
21:01
force application was a limitation, causing some
21:04
variability, it was fundamental work. Kaplan
21:08
and Kader also contributed to this biomechanical
21:11
understanding. And of course, a huge focus in
21:13
knee orthopedics is the ACL, the anterior cruciate
21:16
ligament. What did classic papers reveal about
21:19
outcomes after injury, especially in athletes?
21:23
Noyes and colleagues published important early
21:25
data on this. They followed athletes with ACL
21:28
injuries trying to return to sport. And what
21:30
did they find? Even with the treatments available
21:32
then, only about half managed to get back to
21:35
their previous level by one year. They also reported
21:38
a worrying rate of re -injury. And long -term
21:40
consequences. About half the knees assessed five
21:43
or more years after the injury already showed
21:45
radiographic signs of osteoarthritis. That's
21:48
a challenging picture. Suggests fixing the initial
21:50
injury didn't always prevent long -term problems.
21:52
No, it didn't seem to guarantee a return to normal
21:55
or prevent degeneration. And the source notes
21:58
that despite masses of research since then, there's
22:00
still no absolute consensus on the optimal ACL
22:03
treatment. Why is that still debated? Partly
22:06
the difficulty in doing large prospective studies
22:08
directly comparing surgery versus non -operative
22:11
management. Which brings us to a really thought
22:14
-provoking finding mentioned. Go on. A retrospective
22:17
cohort study by Kessler and colleagues. They
22:20
compared patients with isolated ACL tears treated
22:23
either with reconstruction or conservatively.
22:25
Okay. Reconstruction did reduce secondary meniscal
22:28
tears in their group, but surprisingly, the reconstructed
22:31
knees had a significantly higher rate of osteoarthritis
22:34
later on, 42 % versus 25 % at over 11 years follow
22:40
-up. Wait, reconstruction led to more arthritis
22:42
in that study, not less? That was their finding,
22:45
despite similar activity levels between groups.
22:47
Their conclusion... quoted in the source, was
22:50
that doing ACL reconstruction specifically to
22:52
prevent OA and maintain function cannot be accepted
22:55
unquestioningly. Wow. That really challenges
22:58
a common assumption, doesn't it? It certainly
23:00
does. While it's retrospective data and needs
23:02
careful interpretation, it dramatically challenged
23:05
a widely held belief. It remains a critical discussion
23:08
point. It forces a difficult way up for patients
23:10
and surgeons. Potential stability benefits versus
23:13
a possible increased risk of long -term arthritis.
23:16
Precisely. It shows that even after decades of
23:18
research, fundamental questions about optimizing
23:21
ACL outcomes persist. A powerful reminder that
23:24
research can overturn accepted wisdom. And the
23:27
meniscus, similar story regarding long -term
23:29
consequences of surgery. Yes. Johnson and colleagues'
23:33
paper on long -term outcomes after meniscectomy
23:35
from the University of Iowa series, looking back
23:38
at patients from 1936 to 1956, was very influential.
23:42
Mean follow -up was 17 .5 years. And their key
23:45
findings. A high incidence of poor results after
23:48
removing the meniscus, ongoing pain, degenerative
23:50
arthritis, laxity, reduced flexion. Strikingly,
23:53
76 % of the operated knees showed Fairbanks changes.
23:56
radiographic signs of OA compared to only 6 %
24:00
in the other knee. So a strong link between meniscectomy
24:03
and later arthritis. A very strong link. The
24:05
frequency of unsatisfactory clinical results
24:07
correlated directly with number of radiographic
24:09
changes. It powerfully showed the meniscus' crucial
24:12
role in load bearing and stability, maybe not
24:14
fully appreciated when removal was common. Even
24:17
with study limitations from that era. Yes, lacking
24:20
detailed stats, pre -injury levels, quality of
24:23
life measures typical for the time. But the core
24:25
message about degenerative consequences was clear
24:28
and drove the shift toward preserving meniscal
24:30
tissue whenever possible. And just like the hip,
24:33
evaluating the knee required scoring systems
24:36
and classifications. Indeed. For radiographic
24:39
OA, you have Allback, IQDC, Kilgren -Lawrence,
24:43
Fairbank, multiple systems. which makes comparing
24:46
studies tricky. Fairbank remains popular, probably
24:49
due to its simplicity. And assessing cartilage
24:52
damage during arthroscopy. That sounds subjective,
24:55
too. It can be. Brismar and Spahn looked at the
24:57
reliability of systems like outer -bridge grading.
25:00
Spahn's survey found surgeons felt it didn't
25:02
differentiate middle grades well. And Brismar's
25:05
study confirmed reliability issues. Yes. Good
25:07
reliability for the surgeon scoring the same
25:09
lesion again, intra -observer, for normal or
25:11
severe grade four damage, but poor for middle
25:14
grades. And even worse, poor agreement between
25:16
different surgeons into observer, sometimes as
25:19
low as 61%. So different surgeons might grade
25:21
the same damage differently. Quite significantly.
25:24
Even combining grades didn't fully solve it for
25:26
distinguishing moderate damage. It raised valid
25:29
questions about the consistency, maybe even the
25:31
validity, of arthroscopic grading. Even visual
25:35
assessment has variability. What about patient
25:37
scores versus surgeon scores? Scores like the
25:40
Knee Society rating system are filled out by
25:42
the physician. The source points out the potential
25:45
for bias. The surgeon might unconsciously rate
25:48
things slightly better, wanting to show success.
25:51
And patients and doctors might rate pain differently
25:53
anyway. Research shows they do, which makes comparing
25:56
physician -administered scores directly with
25:59
patients' self -reported ones like WOMAC or SF
26:02
-36 difficult. Both perspectives matter. but
26:05
they capture different things. Finally, the Tegner
26:08
activity scale. Widely used, often with a Lysol
26:11
Mee score. Its main strength is evaluating changes
26:14
in an individual patient's activity level after
26:16
injury or surgery. Are they getting back towards
26:18
their desired sport or work level? It tracks
26:21
progress within that patient. This trip through
26:23
the spine and knee echoes themes from the hip,
26:26
doesn't it? classification challenges, evolving
26:29
surgery based on outcomes, the search for reliable
26:32
assessment. Okay, let's blot it out again. Other
26:35
joints, basic science insights, and research
26:38
principles themselves. Absolutely critical areas.
26:40
In the shoulder, for instance, NEAR's work on
26:43
impingement is foundational. What were his key
26:45
contributions there? He described the three stage
26:47
process for subacromial impingement, the rotator
26:50
cuff tendons getting compressed. He detailed
26:53
a clinical test for it and presented anterior
26:56
acromioplasty, removing part of the bone as a
26:59
treatment and surgical access for cuff repairs.
27:01
Really clarified that common problem. Down to
27:04
the hand and wrist carpal tunnel syndrome. Very
27:06
common. Phalen's paper massively increased recognition.
27:10
He detailed the classic symptoms accurately,
27:12
the numbness, tingling night. pain in the median
27:14
nerve area and shared his surgical experience
27:17
helping standardize decompression. And Gelberman
27:19
added objective proof. Yes, by measuring endocarpal
27:22
canal pressures. Confirmed pressure is significantly
27:25
higher in CTS, increases dramatically with wrist
27:28
flexion from 32 millimillimilligene neutral up
27:31
to 94 millimillimilligene at 90 degrees flexion,
27:34
and drops immediately after surgical release.
27:38
Physiological evidence supporting the compression
27:40
theory. Napier's work on hand movement sounds
27:42
quite fundamental too. A true classic. Napier
27:45
provided a basic functional classification. The
27:48
precision grip for fine tasks. And the power
27:51
grip for forceful grasping. The anatomical and
27:54
functional basis for how we use our hands. A
27:57
framework for understanding prehension. And for
28:00
common risk fractures, like calls. Gartland and
28:02
Whirly's paper was influential there. They aimed
28:04
to find factors predicting poor results after
28:06
a call -less fracture and evaluated standard
28:09
manipulation and casting outcomes. Studied patients
28:12
at one hospital, providing practical insights.
28:14
Carpal instability, a complex wrist problem.
28:17
Kolesnik's concepts were particularly insightful.
28:20
He focused on the lunate bones position, described
28:22
the carpus, the wrist bones, as two functional
28:25
rows linked by the scaphoid, like a rigid connecting
28:28
rod. And the ligament connection. The scapholunate
28:30
ligament as the key coupling, using a slider
28:33
crank analogy. He coined scapholunate dissociation
28:37
for the gap and displacement seen after injury,
28:39
suggesting it might be more common than static
28:41
x -rays showed. And highlighted the long -term
28:43
risks. Yes. Increased risk of scaphoid non -union
28:47
and progressive arthritis, what he termed SLAC
28:50
risk. Scapholunate advanced collapse from that
28:53
untreated instability. The source also flags
28:55
key papers on the triangular fibrocartilage complex,
28:59
TFCC, by Fisher, Thompson, and Harrison, moving
29:02
down to the foot -rimitoid forefoot deformity.
29:05
The source highlights a salvage operation description,
29:08
excising the deformed metatarsal heads and crucially
29:10
repositioning the plantar plate. What were the
29:13
advantages? Two key things. It replaced the foot's
29:16
weight -bearing pad, often drawn upwards in the
29:18
deformity, and gave a better cosmetic result
29:20
by straightening the toes rather than just removing
29:22
them. And for chronic ankle instability after
29:24
sprains, Brostrom's paper sounds significant.
29:27
Highly significant. It challenged the belief
29:30
that torn lateral ligament ends just shriveled
29:33
up, making repair impossible. Brostrom showed
29:36
excellent results with direct anatomical repair.
29:39
Crucial, as chronic instability affects 10 -20
29:42
% after a sprain. And later studies supported
29:45
his approach. Yes, Cripps' multi -center series,
29:48
referenced, found anatomical reconstruction like
29:51
Brostrom's gave better function, stability, and
29:54
less long -term OA compared to older tinnadesis
29:57
procedures even years later. But a note of caution
30:00
from biomechanics. Waldrop's study showed that
30:03
even modern suture repairs are initially much
30:05
weaker, less than half the strength of the native
30:07
ligament at time zero. Underscores the need for
30:10
careful protection and rehab to avoid early failure.
30:13
That covers a lot of joints. Let's shift now
30:15
to the fundamental basic science insights that
30:18
underpin orthopedics. Articular cartilage repair,
30:21
still a challenge. Mankin's work really captures
30:23
the complexity and controversy. How does cartilage
30:26
heal after injury? True high -aligned cartilage.
30:29
Or inferior fibrocartilage. Terminology confusion,
30:32
too. Relevant for arthroscopic shaving technique.
30:34
Very relevant. Mankin questioned if debridement
30:37
itself stimulates repair. Or if changes are due
30:40
to other factors, like altered synovial fluid.
30:43
Critical questions. And where do the repair cells
30:45
actually come from? Shapiro's rabbit study gave
30:48
a key insight for full -thickness defects going
30:50
down to bone. They found that cartilage -like
30:53
repair tissue was populated by cells originating
30:55
from the underlying bone marrow. Not from the
30:57
existing cartilage edges. No, the native chondrocytes
31:01
didn't seem to participate. The repair cells,
31:04
fibrocartilaginous in nature, came from the marrow.
31:06
This underpins strategies like microfracture
31:09
that access the marrow. And influencing that
31:11
repair process, Salter's work on continuous passive
31:14
motion, CPM. Foundational. Salter's research
31:18
fundamentally changed post -op rehab. His experiments
31:21
show CPM gently moving the joint passively promoted
31:23
healing with more high -line -like cartilage
31:26
in animals, compared to immobilization, which
31:28
led to fibrocartilage and stiffness. How did
31:31
CPM help? It increased production of glycosaminoglycans,
31:34
key matrix components leading to better functional
31:36
outcomes, provided the scientific basis for using
31:39
CPM machines after various joint surgeries. And
31:42
those mesenchymal stem cells from the marrow?
31:44
The source mentions MSC's multipotent mesenchymal
31:48
stromal cells. Building on the marrow's role,
31:51
studies like Wakitani's explored transplanting
31:54
MSCs into defects in rabbits, showing they could
31:57
form chondrocytes. demonstrated the potential
31:59
for cell -based repair. Bone regeneration, another
32:02
area with huge basic science impact. Absolutely.
32:06
Marshall Eurist's discovery of bone morphogenetic
32:08
proteins, BMPs, was a landmark. He found demineralized
32:12
bone matrix, DBM, could induce new bone formation
32:16
even in muscle. Leading him to identify BMPs.
32:19
Yes, the specific protein factors within DBM
32:22
responsible for this powerful bone -inducing
32:24
effect. BMPs recruit stem cells from surrounding
32:27
tissues into a defect and make them differentiate
32:30
into bone -forming osteoblasts. Making them incredibly
32:32
valuable tools. Hugely valuable biologically
32:34
for stimulating bone healing and fusion in difficult
32:37
situations. Understanding the mechanical properties
32:39
of these tissues is also vital. Cartilage biomechanics
32:42
sounds complex. As highlighted by Tsai and Grodzinski,
32:45
lab studies testing cartilage under simple compression
32:47
say provide information, but don't fully mimic
32:50
the complex loading inside a living joint. So
32:53
extrapolating bench findings clinically is challenging.
32:56
But mechanical forces definitely matter. Oh,
32:59
profoundly. They affect chondrocyte metabolism
33:02
and health. That's clear. And quantifying tissue
33:04
components needed specific lab techniques. Yes.
33:07
Measuring matrix components reliably was important.
33:10
Farndale developed a rapid spectrophotometric
33:13
method using DMMB dye for estimating JAGs, key
33:17
cartilage components, much simpler than older
33:19
methods. And for histology? Rosenberg found saffron
33:22
and O -stain bind specifically to the polyanions
33:25
in GAGs, not collagen. Very useful for visualizing
33:28
proteoglycan distribution and quantity in tissue
33:31
sections. Shifting to soft tissue grafts, ligament
33:34
graft integration after ACL reconstruction, for
33:36
example. Understanding that healing is key for
33:39
rehab. Vital. Success depends on secure initial
33:41
fixation, graft integrity, and then biological
33:44
remodeling. With more hamstring grafts used,
33:47
partly due to patellar tendon graft donor site
33:49
issues. Pain, weakness. Exactly. Understanding
33:52
how that tendon graft heals into the bone tunnels
33:54
is critical for safe rehab. have timelines. Biological
33:58
fixation happens as the tendon incorporates into
34:00
the bone. And for bone itself, how implants integrate
34:03
osseointegration. Fitzpatrick's analysis gave
34:06
crucial insights into the mechanics needed. Osseointegration
34:09
direct bone implant connection requires close
34:12
contact and minimal micro motion. Thresholds
34:14
for movement. Yes. Over 150 micrometers of motion
34:18
leads to fibrous tissue. Between 40, 150, a mix.
34:21
But below about 20 micrometers, you get predominantly
34:24
bone forming right against the implant. Fundamental
34:27
for rigid fixation, especially with titanium.
34:29
The idea that bone adapts to load, Wolf's Law,
34:33
is also central. Jones' paper provided compelling
34:36
human evidence. Study tennis players' arms. found
34:38
significant hypertrophy thicker cortex, nearly
34:41
35 % more in men, over 28 % in women on the playing
34:45
side, helped solidify that loading build stronger
34:47
bone. Turner's work too. Yes, demonstrated in
34:50
animals how different loads affect bone formation,
34:52
needing load to maintain mass. Proposed rules
34:55
for bone adaptation based on experiments. And
34:58
when bone mass is lost, osteoporosis. What did
35:02
basic science show was the core problem? Jowsey's
35:05
quantitative micro radiography of biopsies was
35:08
pivotal, showed bone forming surfaces were relatively
35:11
normal in osteoporosis, but bone resorbing surfaces
35:15
were dramatically increased two to four times
35:17
higher. So the key message was? Osteoporosis
35:20
is primarily driven by excessive bone resorption,
35:23
not defective formation. That fundamentally shifted
35:26
treatment strategies towards anti -resorptive
35:28
therapies. These basic science insights from
35:31
cell biology to biomechanics are clearly the
35:33
foundation for so much practice. Okay, let's
35:36
wrap up by looking at the principles of research,
35:39
evidence evaluation, and scientific communication
35:41
as the source discusses. A critical section this,
35:44
how we generate and interpret knowledge. It starts
35:47
with a real visionary, Ernest Codman, back in
35:49
the early 20th century. Codman emphasized tracking
35:52
outcomes. Precisely. His core idea, revolutionary
35:55
then, was that to improve, clinicians must systematically
35:58
collect and study data on their treatments and
36:00
patient outcomes. His end result system idea.
36:03
And his bone tumor registry concept. Prescient,
36:06
though it struggled for support initially, highlighted
36:09
the need for collaborative data collection, especially
36:12
for rare conditions. For managing musculoskeletal
36:14
tumors today, staging systems are vital. Anikin's
36:17
system was a major advance. It aimed to incorporate
36:20
prognostic factors grade, extend to stratify
36:23
risk, guide surgery aggressiveness and inform
36:26
decisions about chemotherapy or radiation. Based
36:28
on great extent metastases. Yes. Endorsed by
36:32
the Musculoskeletal Tumor Society, MSTS, it became
36:35
the standard for sarcomas, influencing later
36:38
systems like AJCC. And evaluating outcomes after
36:41
tumor treatment, especially limb salvage. The
36:43
MSPS also developed a specific numerical scoring
36:46
system for that. Uses a 0 -5 scale across categories
36:49
like pain, function, emotional acceptance, support
36:52
use, gate satisfaction. And it's reliable. Field
36:56
tested showed low intraobserver variability,
36:59
recommended for comparing results of different
37:01
reconstruction techniques after tumor removal.
37:03
A critical, sometimes tricky, part of tumor management
37:06
is the biopsy. Malauer's paper stresses how fundamentally
37:09
important a well -planned biopsy is. An inappropriate
37:12
one badly placed too small contaminating tissue
37:15
can lead to misdiagnosis, delays, even needing
37:18
a bigger, potentially avoidable operation like
37:20
amputation. So, key principles for biopsy. Turning
37:38
to broader evidence -based medicine principles,
37:41
the hierarchy of evidence RCTs at the top, the
37:44
source adds nuance here. RCTs and meta -analyses
37:51
are generally top for treatment effectiveness
37:53
due to minimizing bias. But. But, the source
37:55
rightly notes, a well -done, non -randomized
37:58
trial or large cohort study can sometimes provide
38:01
equally good, maybe better evidence. And as we
38:04
said with Charley and Ponsetti, impactful case
38:06
series, level 4, can change practice entirely.
38:09
Sometimes doing an RCT becomes unethical if one
38:12
treatment is clearly superior. So it's study
38:14
quality and effect magnitude, not just the design
38:17
label. Exactly. The source also distinguishes
38:20
evidence users, clinicians applying appraised
38:23
evidence from evidence generators, researchers
38:25
doing the studies. Most clinicians are a mix.
38:28
And grades of recommendation systems help users.
38:31
They try to. Systems like JBJS's four grades
38:34
or the grade system link recommendations to evidence
38:37
level. Developed by experts, they offer explicit
38:40
guidance. Grade A might mean Definitely change
38:43
practice. Grade B, probably. But potential pitfalls.
38:47
A concern raised is applying grades too rigidly,
38:49
without considering the individual patient's
38:51
context and values. The heparin example for joint
38:54
replacement prophylaxis highlights this individual
38:57
risk matters. Critical thinking always needed.
38:59
Appraising different study types requires different
39:01
scrutiny. Absolutely. Case reports, level five,
39:04
useful for rare things, hypotheses, but high
39:07
bias risk. Case series, level five, multiple
39:10
patients, similar issues, prone to bias, especially
39:13
selection bias, are the patient's typical. What
39:15
to check in a case series? How are patients chosen?
39:18
Diagnosis treatment decided. Data collected accurately.
39:21
Did authors discuss limitations honestly? And
39:24
RCTs, the gold standard, still need careful appraisal.
39:27
Definitely. Methodological rigor is everything.
39:30
Check for bias. With randomization truly random
39:32
and concealed, was lost to follow up high or
39:35
different between groups, proper randomization,
39:37
number tables, bone surface, is better than quasi
39:40
methods. Also check outcomes. Yes. Were primary
39:43
secondary outcomes clear? Measured well with
39:45
validated tools. Is the difference found clinically
39:48
significant, not just statistically? Does it
39:50
actually matter to patients? And combining studies
39:53
in meta -analyses. Complex projects prone to
39:56
error interpret cautiously. Check discussion
39:58
for shortcomings. Publication bias. Missing NEGO
40:01
studies. Language bias. Only English studies.
40:05
Flaws. Included studies. Poor methods. Variations
40:07
pulled together. How does it compare to previous
40:10
meta -analyses? Finally, the practicalities of
40:13
scientific writing and publishing in orthopedics.
40:15
An evolving landscape. More journals. Many open
40:18
access online only. Wider reach, maybe more citations,
40:22
but often processing fees, and maybe not indexed
40:25
or high impact factor initially. Key tips for
40:27
writing a manuscript. Stick religiously to journal
40:30
guidelines. Word count, references, reporting
40:33
standards, like consort for RCTs, verify citations.
40:37
Get reviews, supervisor, colleagues, maybe linguistic
40:40
help. All authors must approve the final version.
40:43
Submission needs cover letter, conflicts, ethics
40:46
approval, disclosure of prior presentations.
40:48
And journal impact factors, not without controversy.
40:51
Their calculation is debated. The two -year citation
40:53
window might not suit all fields. What counts
40:55
as a citation or a citable item is debated. And
40:58
national bias exists, researchers citing work
41:00
from their own country more often, influencing
41:02
IFs. And lastly, internal versus external validity.
41:06
Internal validity. Are the study's conclusions
41:08
accurate within that study, free from bias, external
41:10
validity? Can the findings be generalized to
41:12
other patients, settings, surgeons? The source
41:15
notes external validity is often poorly investigated
41:17
in orthopedic papers. A finding in one specific
41:19
group might not hold true elsewhere. We have
41:22
certainly covered a huge amount today. Peeling
41:24
back the layers on classic papers, tracing the
41:27
evolution of hip, spine, knee treatments, diving
41:30
into basic science, and examining research principles.
41:33
It really has been a journey through the bedrock
41:35
of orthopedics. Seeing how classic means transformative
41:39
impact, not just citations. Tracing how THA refined
41:43
through understanding failures like particle
41:45
disease. And grappling with the tools, outcome
41:48
scores, classifications, x -rays acknowledging
41:50
their strengths, but also their limits and the
41:52
need for the patient perspective. The basic science
41:55
highlights that constant quest to understand
41:57
tissue biology, marrow cells and cartilage repair,
42:01
mechanical forces on bone, the power of BMPs.
42:04
And the research principles discussion really
42:06
underscores that critical appraisal is key. Understanding
42:09
evidence, hierarchies, bias, study design. It's
42:12
not just about having research, but interpreting
42:15
it wisely. It shows orthopedics is dynamic, built
42:18
on this history. Each classic paper often solved
42:20
the problem, but raised new questions, driving
42:22
more research. Understanding these foundations
42:25
gives invaluable context for current practice
42:27
and equips you to critically evaluate new information,
42:31
seeing how knowledge builds, step by step. Appreciating
42:34
the lineage of our understanding, yes. If you
42:36
found this deep dive valuable, please do consider
42:39
rating and sharing it with colleagues who might
42:42
also find it usable. And as we look at ongoing
42:44
debates like ACL reconstruction versus long -term
42:47
OA risk or the challenges in true cartilage repair,
42:51
issues highlighted even in these classic papers,
42:53
it's clear many fundamental questions remain.
42:56
How do we best integrate lessons from seminal
42:59
works with evolving evidence, different study
43:01
qualities, and crucially, the unique needs of
43:04
each individual patient? That remains the central
43:06
ongoing challenge for us all in orthopedics today.